Takeda Pharmaceutical Co Ltd

Q4 2023 13F Holdings Report, Stock Holdings

Signature - Title
Amit Singh - Senior Vice President and Head of Treasury
Location
Tokyo, Japan
Holdings as of
December 31, 2023
Value $
$327M
Num holdings
14
Date filed
2/13/2025, 06:13 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included HLVX, DNLI, PHAT, OVID, and STTK.
Next filing
Q1 2024 - Feb 13, 2025
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Amit Singh Senior Vice President and Head of Treasury Tokyo, Japan 2/13/2025

Other Included Managers (1):

Num Name Location File Number
1 Takeda Vaccines, Inc. Cambridge, MA 028-24939